In the Daily Caller: Rand Paul And Al Franken Come Together For Weed
Republicans and Democrats in Congress are introducing medical marijuana legislation Thursday protecting states from federal interference in the wake of a request to roll back protections from Attorney General Jeff Sessions.
Members of the House of Representatives and Senate are backing a comprehensive marijuana package in an effort to protect state medical legalization laws from a potential federal crackdown. The bill gives the Department of Veteran Affairs the freedom to recommend medical marijuana to patients and removes cannabidiol (CBD), used to treat chronic pain and severe epilepsy, from the Controlled Substances Act.
Republican Sens. Mike Lee, Rand Paul and Lisa Murkowski join Democratic Sens. Al Franken, Cory Booker and Kirsten Gillibrand as initial sponsors of the legislation, which they will announce in a press conference Thursday. A version of the legislation in the House is also attracting bipartisan support.
Here are some of the provisions of that bill:
Amends the Controlled Substances Act (CSA) to provide that control and enforcement provisions of such Act relating to marijuana shall not apply to any person acting in compliance with state law relating to the production, possession, distribution, dispensation, administration, laboratory testing, or delivery of medical marijuana.
Transfers marijuana from schedule I to schedule II of the CSA.
Excludes “cannabidiol” from the definition of “marijuana” and defines it separately as the substance cannabidiol, as derived from marijuana or the synthetic formulation, that contains not greater than 0.3% delta-9-tetrahydrocannabinol on a dry weight basis. Deems marijuana that is grown or processed for purposes of making cannabidiol, in accordance with state law, to meet such concentration limitation unless the Attorney General determines that the state law is not reasonably calculated to comply with such definition.
Prohibits a federal banking regulator from: (1) terminating or limiting the deposit insurance of a depository institution solely because it provides or has provided financial services to a marijuana-related legitimate business; or (2) prohibiting, penalizing, or otherwise discouraging a depository institution from providing financial services to a marijuana-related legitimate business. […]